已收盤 11-14 16:00:00 美东时间
+0.080
+0.37%
Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.55) by 1.28 percent. This is a 42.11 percent decrease over losses of $(0.38) per share
11-11 05:04
Capricor Therapeutics, Inc. (CAPR) is scheduled to announce Q3 earnings results on Monday, November 10th, after market close. The consensus EPS Estimate is -$0.54 and the consensus Revenue Estimate is...
11-08 06:35
Capricor Therapeutics (NASDAQ:CAPR) is set to give its latest quarterly earning...
11-08 03:04
Anova Metals Ltd. ( ($AU:WA8) ) has provided an announcement. Warriedar Resourc...
11-06 19:58
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
11-06 09:55
Capri Holdings Ltd (NYSE: CPRI) reported mixed Q2 results with an adjusted loss of 3 cents/share, missing expectations for profit.
11-05 03:57
Capri Holdings (NYSE:CPRI) affirms FY2026 GAAP EPS guidance from $1.20-$1.40 to $1.20-$1.40 vs $1.32 analyst estimate. Affirms FY2026 sales outlook from $3.375 billion-$3.450 billion to $3.375 billion-$3.450 billion vs
11-04 19:50
Capri press release (CPRI): Q2 Non-GAAP EPS of -$0.03 misses by $0.17. Revenue of $856M (-20.7% Y/Y) beats by $29.45M. Fiscal Year 2026 Outlook For Capri Holdings, the Company expects the following: T...
11-04 19:48
Capri Holdings (NYSE:CPRI) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.13 by 122.56 percent. This is a 104.62 percent decrease over earnings of $0.65 per share from
11-04 19:46
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12